Cabrini Development Council v. LCA-Vision, Inc.

197 F.R.D. 90, 2000 U.S. Dist. LEXIS 14219, 2000 WL 1469307
CourtDistrict Court, S.D. New York
DecidedSeptember 28, 2000
DocketNos. 97 Civ. 8671 DC, 98 Civ. 8387 DC
StatusPublished
Cited by6 cases

This text of 197 F.R.D. 90 (Cabrini Development Council v. LCA-Vision, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cabrini Development Council v. LCA-Vision, Inc., 197 F.R.D. 90, 2000 U.S. Dist. LEXIS 14219, 2000 WL 1469307 (S.D.N.Y. 2000).

Opinion

OPINION

CHIN, District Judge.

In 1995, CDC Operations, Inc. (“CDCO”), New York Refractive Eye Associates, P.C. (the “P.C.”), and LCA-Vision, Inc. (“LCA”) formed Excimer Associates, LLC, a New York limited liability company, for the purpose of opening a New York City center offering photorefractive keratectomy (“PRK”), a laser eye procedure to correct myopia. The joint venture failed, and these consolidated diversity actions — together alleging sixteen causes of action — are the result.

Presently before the Court are the parties’ cross-motions for summary judgment pursuant to Fed.R.Civ.P. 56.1 In the course of [92]*92considering the motions the Court realized that it does not have subject matter jurisdiction over the first action, docket number 97 Civ. 8671, because complete diversity of citizenship between the parties does not exist. Accordingly the first action is remanded to the New York Supreme Court pursuant to 28 U.S.C. § 1447(c) for lack of subject matter jurisdiction. With respect to the second action, docket number 98 Civ. 8387, the P.C.’s motion is granted only to the extent that I hold LCA lacks standing to assert Excimer’s claim. Because Excimer is an indispensable party to the action whose joinder would destroy diversity jurisdiction, the second action is dismissed without prejudice and without costs.

BACKGROUND

A. Facts

In late 1994, LCA approached non-party Cabrini Medical Center (the “Hospital”), its affiliate Cabrini Development Council (“Cabrini”), and certain ophthalmologists about developing a New York City center offering PRK services. To further their plan, LCA and the Hospital entered into a Development Agreement dated March 6, 1995. (Cabrini Am.Compl., Ex. A). Because the Hospital is a not-for-profit corporation whose activities are limited by statute, the Development Agreement contemplated the creation of a new for-profit entity — CDCO—that would assume the Hospital’s rights and obligations under the Development Agreement and would take part in the PRK venture. (Id.). CDCO, LCA, and the P.C. then created Ex-cimer and entered into an Operating Agreement. (Cabrini Am.Compl.Ex. B).

The Operating Agreement required CDCO, LCA, and the P.C. to make initial capital contributions to Excimer. Both CDCO and LCA made their initial contributions in accordance with the Operating Agreement. (LCA 56.1 113). LCA alleges that the P.C. failed to make its required capital contribution. (LCA 56.1 H3). LCA further alleges that it made substantial additional contributions to Excimer that CDCO failed to match. (LCA 56.1 114). CDCO denies that the capital contributions were unequal. (CDCO/Excimer 56.1 Opp. U 4).

In late 1995 or early 1996, Excimer began operating a single, unprofitable PRK center in Manhattan. (LCA 56.1 II7; CDCO/Excimer 56.1 Opp. H 7). Soon thereafter, Ex-cimer entered into negotiations to acquire an additional PRK center located in Mt. Kiseo, New York. (LCA 56.1 118; CDCO/Excimer 56.1 Opp. U 8). According to CDCO and Excimer, Excimer agreed to acquire the Mt. Kisco Center. Before it could do so, however, LCA acquired the center for itself, thereby usurping a corporate opportunity that rightly belonged to Excimer. (CDCO/Excimer 56.1 Opp. 118).

Apparently disenchanted with the joint venture, CDCO offered to sell its interest in Excimer to LCA in February 1997. (LCA 56.1 H13; CDCO/Excimer 56.1 Opp. H 13). The parties initially thought that under the terms of the Operating Agreement, CDCO was not allowed to sell its interest in Excimer without the written consent of all members. Accordingly, CDCO and LCA sought, but were unable to obtain, the P.C.’s consent to complete the sale. (LCA 56.1 Hf 15 — 16; CDCO/Excimer 56.1 Opp. 1111 15-16). The parties dispute whether the sales agreement between LCA and CDCO was binding, in view of the P.C.’s refusal to agree to the sale. Excimer ceased operating in September 1997 when LCA removed the laser and computer from Excimer’s Manhattan PRK center. (CDCO/Excimer 56.1 1129; LCA Answer 1135).

B. The Instant Disputes

The complaint in the first action asserts: (1) a claim for breach of contract by CDCO against LCA; (2) claims for breach of contract, breach of the covenant of good faith and fair dealing, and unjust enrichment by Excimer against LCA; (3) a claim for conversion and theft of a corporate opportunity by Excimer against LCA and its officers or directors (collectively, the “Individual defendants”); and (4) a claim for fraud by Cabrini against LCA and the Individual defendants. In response, LCA asserts counterclaims for breach of contract, promissory estoppel, breach of fiduciary duty and the duty of good [93]*93faith and fair dealing, and prima facie tort against Cabrini and CDCO, and breach of contract and indemnification against Excimer. The parties have cross-moved for summary judgment on all claims except LCA’s counterclaim for indemnification.2

In the second action, LCA alleges claims for breach of contract and promissory estoppel against the P.C. The P.C. filed counterclaims for breach of contract against LCA and for indemnification against Excimer, which is not a party in the second action. The parties cross-move for summary judgment on all claims.

C. Prior Proceedings

The first action, docket number 97 Civ. 8671, was originally filed in the Supreme Court of the State of New York on October 16, 1997 by plaintiffs Cabrini and CDCO, suing individually and derivatively on behalf of and for the benefit of Excimer, a limited liability company, against LCA, the Individual defendants, and Excimer. On November 21, 1997 defendants removed the action to this Coúrt on the basis of diversity of citizenship, 28 U.S.C. § 1332, alleging that complete diversity existed between plaintiffs and defendants and that the amount in controversy exceeded $50,000.3

On January 12, 1998, LCA, the Individual defendants, and Excimer moved to dismiss the complaint pursuant to Fed.R.Civ.P. 12(b)(6). On November 3, 1998,1 denied the motion as moot and granted Cabrini and CDCO leave to file an amended complaint. The amended complaint asserted claims on behalf of Excimer directly, rather than derivatively, and dropped Excimer as a defendant. These motions followed.

DISCUSSION

A. The First Action

1. Subject Matter Jurisdiction

In the course of considering the summary judgment motions, the Court sua sponte raised the issue of subject matter jurisdiction and permitted the parties an opportunity to be heard. See Order dated August 14, 2000; see also Franceskin v. Credit Suisse, 214 F.3d 253, 257 (2d Cir.2000) (court may address subject matter jurisdiction sua sponte at any stage of the proceeding); Rohrer v. FSI Futures, Inc., 981 F.Supp. 270, 276 (S.D.N.Y.1997) (same).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bischoff v. Boar's Head Provisions Co., Inc.
436 F. Supp. 2d 626 (S.D. New York, 2006)
Excimer Associates, Inc. v. LCA Vision, Inc.
292 F.3d 134 (Second Circuit, 2002)
Ochs v. Simon (In Re First Central Financial Corp.)
269 B.R. 502 (E.D. New York, 2001)
Strother v. Harte
171 F. Supp. 2d 203 (S.D. New York, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
197 F.R.D. 90, 2000 U.S. Dist. LEXIS 14219, 2000 WL 1469307, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cabrini-development-council-v-lca-vision-inc-nysd-2000.